Charles R. Hattemer

778 total citations
7 papers, 582 citations indexed

About

Charles R. Hattemer is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Charles R. Hattemer has authored 7 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 3 papers in Surgery and 1 paper in Pulmonary and Respiratory Medicine. Recurrent topics in Charles R. Hattemer's work include Acute Myocardial Infarction Research (4 papers), Coronary Interventions and Diagnostics (3 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). Charles R. Hattemer is often cited by papers focused on Acute Myocardial Infarction Research (4 papers), Coronary Interventions and Diagnostics (3 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). Charles R. Hattemer collaborates with scholars based in United States, Brazil and India. Charles R. Hattemer's co-authors include John Paul Runyon, Cathy Hamilton, W B Gibler, Michael R. Sayre, Richard A. Walsh, John F. Schneider, Eli M. Roth, Dean J. Kereiakes, Thomas M. Broderick and Thomas Shimshak and has published in prestigious journals such as Neurology, The American Journal of Cardiology and American Heart Journal.

In The Last Decade

Charles R. Hattemer

7 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles R. Hattemer United States	6	480	242	215	67	61	7	582
Pierre Legalery France	8	334 0.7×	122 0.5×	168 0.8×	206 3.1×	26 0.4×	10	482
Stephen A. Stowers United States	9	460 1.0×	679 2.8×	135 0.6×	27 0.4×	35 0.6×	15	830
Marc C. Newell United States	10	546 1.1×	194 0.8×	206 1.0×	27 0.4×	207 3.4×	18	680
Jimmy MacHaalany Canada	16	430 0.9×	244 1.0×	257 1.2×	72 1.1×	17 0.3×	26	670
Thomas P. Mast Netherlands	13	976 2.0×	330 1.4×	89 0.4×	51 0.8×	254 4.2×	29	1.1k
José Carlos Sánchez‐Salado Spain	14	319 0.7×	69 0.3×	140 0.7×	32 0.5×	144 2.4×	47	484
W B Gibler United States	4	312 0.7×	228 0.9×	60 0.3×	14 0.2×	85 1.4×	4	389
Rémy Pillière France	12	492 1.0×	300 1.2×	211 1.0×	40 0.6×	26 0.4×	24	630
Marie France Séronde France	12	304 0.6×	78 0.3×	92 0.4×	40 0.6×	33 0.5×	16	406
Andrew Deaner United Kingdom	8	286 0.6×	126 0.5×	100 0.5×	20 0.3×	28 0.5×	22	401

Countries citing papers authored by Charles R. Hattemer

Since Specialization

Citations

This map shows the geographic impact of Charles R. Hattemer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles R. Hattemer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles R. Hattemer more than expected).

Fields of papers citing papers by Charles R. Hattemer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles R. Hattemer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles R. Hattemer. The network helps show where Charles R. Hattemer may publish in the future.

Co-authorship network of co-authors of Charles R. Hattemer

This figure shows the co-authorship network connecting the top 25 collaborators of Charles R. Hattemer. A scholar is included among the top collaborators of Charles R. Hattemer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles R. Hattemer. Charles R. Hattemer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Dippel, Eric J., Dean J. Kereiakes, Thomas M. Broderick, et al.. (2001). Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: An algorithm for percutaneous management. Catheterization and Cardiovascular Interventions. 52(3). 279–286. 95 indexed citations

Kereiakes, Dean J., Robert L. Obenchain, Beth Barber, et al.. (2000). Abciximab provides cost-effective survival advantage in high-volume interventional practice. American Heart Journal. 140(4). 603–610. 20 indexed citations

Kereiakes, Dean J., Thomas M. Broderick, Eli M. Roth, et al.. (1999). Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention. The American Journal of Cardiology. 84(4). 391–395. 103 indexed citations

Hattemer, Charles R., et al.. (1997). Ergonovine-Testing-Directed Therapy and Long-Term Outcome of Sudden-Death Survivors withNo Apparent Heart Disease. Cardiology. 89(1). 76–78. 2 indexed citations

Albers, Gregory W., et al.. (1997). Clinical characteristics and management of acute stroke in patients with atrial fibrillation admitted to US university hospitals. Neurology. 48(6). 1598–1604. 48 indexed citations

Gibler, W B, John Paul Runyon, Michael R. Sayre, et al.. (1995). A Rapid Diagnostic and Treatment Center for Patients With Chest Pain in the Emergency Department. Annals of Emergency Medicine. 25(1). 1–8. 309 indexed citations

Hattemer, Charles R., et al.. (1991). Internal medicine residentsʼ monitoring of their colleaguesʼ moonlighting activities at the University of Cincinnati. Academic Medicine. 66(11). 705–6. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact